SCHEMBL6924640

SCHEMBL6924640

Fc1ccc(C2=CCN(Cc3ccccc3)CC2)cc1F

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
HDAC4 P56524 1/20 0.54
SIGMAR1 Q99720 2/20 0.53
MAPK1 P28482 1/20 0.53
DRD4 P21917 7/20 0.51
NPSR1 Q6W5P4 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
NAMPT P43490 1/20 0.51
OPRM1 P35372 1/20 0.50
OPRK1 P41145 1/20 0.50
DRD3 P35462 5/20 0.49
DRD2 P14416 5/20 0.49
PARP1 P09874 1/20 0.49
HTR1A P08908 2/20 0.49
HTR2A P28223 1/20 0.49
HTT P42858 1/20 0.49
HTR6 P50406 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6683584 0.88 MEN1 (0.53) MEN1KMT2AHDAC4SIGMAR1MAPK1
SCHEMBL1824893 0.86 SIGMAR1 (0.40) MEN1KMT2AHDAC4SIGMAR1MAPK1
SCHEMBL2395917 0.86 MAPK1 (0.69) MEN1KMT2AHDAC4SIGMAR1MAPK1
SCHEMBL10287534 0.84 SIGMAR1 (0.71) HDAC4SIGMAR1DRD4NAMPTOPRM1
SCHEMBL6585625 0.84 DRD4 (0.63) MEN1KMT2AHDAC4SIGMAR1MAPK1
SCHEMBL2395932 0.84 DRD4 (0.67) HDAC4SIGMAR1MAPK1DRD4NAMPT
SCHEMBL6043125 0.84 MEN1 (0.58) MEN1KMT2AHDAC4MAPK1DRD4
SCHEMBL2392338 0.83 DRD4 (0.56) MEN1KMT2AHDAC4SIGMAR1MAPK1
SCHEMBL6042349 0.82 SIGMAR1 (0.59) MEN1KMT2AHDAC4SIGMAR1DRD4
SCHEMBL2395803 0.81 LMNA (0.60) MEN1KMT2AHDAC4SIGMAR1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004058727-A1 SUBSTITUTED 3,5-DIHYDRO-4H-IMIDAZOL-4-ONES FOR THE TREATMENT OF OBESITY BAYER PHARMACEUTICALS CORPORATION (US) 2004-07-15 WO disclosed